A new Penn-led randomized controlled trial has found that AI-powered chatbots can make vaccine-hesitant parents more likely ...
New study results could lead to better insurance coverage of the devices for people who don’t take insulin, a researcher said ...
Multi Radiance Medical (MRM), a global leader in Super Pulsed Laser therapy technology and photobiomodulation research, announces that the U.S. Food and Drug Administration (FDA) has granted NHN 510 ...
FDA cleared the Harmony-HHT Phase 1/2 study design, enabling Atavistik Bio to leverage existing clinical data with ATV-1601 and advance directly into a randomized study with indiv ...
In the REIMAGINE I trial among patients early in the course of type 2 diabetes, the higher and lower CagriSema doses led to 1 ...
A Dexcom continuous glucose monitor (CGM) helped adults with type 2 diabetes not using insulin improve blood sugar control in ...
Dexcom anticipates that the findings could drive a shift in the standard of care for type 2 diabetes patients who do not use ...
OriC ( The "Company" or "Oricell") , announced that its proprietary GPC3-targeted autologous CAR-T therapy, Ori-C101, has received clearance from China's ...
Research suggests that equal servings of animal protein may pack a much bigger muscle-building punch than their plant-based ...
Type 2 diabetes is a heterogeneous disease with multiple functional defects in which weight excess has a major role. The contribution of the gut has been increasingly emphasised in recent years, ...
Use of automated insulin delivery during hospitalization may improve glycemic outcomes for adults with insulin-treated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results